Zyrtec is owned by Kenvue (the United States, NYSE: KVUE), which was separated from Johnson & Johnson on 23 August 2023.[1][2] Before Kenvue, Zyrtec was owned by Johnson & Johnson from 2006 to 2023.[2]
Zyrtec is a cetirizine antihistamine developed in Belgium and sold on prescription for years before moving over the counter in the United States in 2008. Kenvue sells the over-the-counter version in the United States; rights elsewhere are held by other companies, so the brand has different owners by market.
Johnson & Johnson separated its consumer health business as Kenvue, which listed in May 2023 and was fully split off through an exchange offer completed on 23 August 2023. Tylenol, Band-Aid, Listerine, Neutrogena and Johnson's Baby all moved to the new company.
No tagged news items yet. Headlines are added nightly from public feeds; only titles and links are stored.
Headlines link to the original publisher. Brandtree does not reproduce article text.
Frequently asked questions
Who is the parent company of Zyrtec?
⌄
The parent company of Zyrtec is Kenvue, a publicly listed company headquartered in the United States.
Is Zyrtec Belgian or American?
⌄
Zyrtec originated in Belgium in 1987, but it is owned today by Kenvue, which is headquartered in the United States. So Zyrtec is a Belgian-origin brand under American ownership.
Since when has Kenvue owned Zyrtec?
⌄
Kenvue has owned Zyrtec since 23 August 2023.
Who owned Zyrtec before Kenvue?
⌄
Before Kenvue, Zyrtec was owned by Johnson & Johnson from 2006 until 2023.
Is Zyrtec still owned by Kenvue?
⌄
Yes. As of 6 September 2026, Zyrtec is still owned by Kenvue. The ownership record was last checked against primary sources on that date.
Sources (2) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.